Skip to content

Effectiveness Analysis of Remimazolam Besylate Combined with Propofol for Bronchoscopy in Tuberculosis Patients

Effectiveness Analysis of Remimazolam Besylate Combined with Propofol for Bronchoscopy in Tuberculosis Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122844
Enrollment
Unknown
Registered
2026-04-20
Start date
2025-05-15
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Interventions

Remimazolam-Propofol Combination Group:Five minutes before anesthesia induction, administer 3 mL of 2% lidocaine hydrochloride gel by instilling it into the nostril on the side intended for scope inse
Propofol Group:Five minutes before anesthesia induction: Instill 3 mL of 2% lidocaine hydrochloride gel into the nostril on the side intended for scope insertion. Have the patient hold an equivalent

Sponsors

Department of Anesthesiology, Huai'an Fourth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients with pulmonary tuberculosis or suspected pulmonary tuberculosis who were to undergo diagnostic bronchoscopy; 2. Ages 18-70 years; 3. BMI 15.5-30 kg/m^2; 4. ASA I-III.

Exclusion criteria

Exclusion criteria: Patients have a history of severe heart,lung,kidney and metabolic system diseases;Patients with epilepsy or mental illness;Drug or alcohol abuse,narcotic analgesics and s1. Patients have a history of severe heart, lung, kidney and metabolic system diseases; 2. Patients with epilepsy or mental illness; 3. Drug or alcohol abuse, narcotic analgesics and sedatives; 4. Pregnant or lactating women; 5. Those who have participated in other drug trials within three months; 6. People with myasthenia gravis; 7. Patients with allergy to the drugs used in this study (benzodiazepines, opioids, propofol, flumazenil and lidocaine, etc.) and contraindications.edatives;Pregnant or lactating women;Those who have participated in other drug trials within three months;People with myasthenia gravis;Patients with allergy to the drugs used in this study (benzodiazepines,opioids,propofol,flumazenil and lidocaine,etc.) and contraindications.

Design outcomes

Primary

MeasureTime frame
Coughing Score;

Secondary

MeasureTime frame
The induction dose of propofol,the number of additional doses and the total amount of propofol;Bronchoscopy Duration; Emergence Time; Discharge Time;Vital Signs at Different Time Points;Adverse Reactions;

Countries

China

Contacts

Public ContactZhao juan

Huai'an Fourth People's Hospital

314826382@qq.com+86 138 5230 5134

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026